Developer docs
API playgroundTry for free, no card

Search company profiles

Azzur Group

Full company profile

uuid0007wm2

Namestring
Azzur Group
Websiteurl
azzur.com
Company typeenum
Private
Founded yearint
2010
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBurlington, United States
HQ citystring
Burlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
GMP cleanroom hosting, pharmaceutical manufacturing services, biotech facility services, environmental monitoring services, GMP warehouse storage
Industry5 codes
PRIMARYHLAAAKAH
GMP Manufacturing Support Services (QA/QMS, validation, documentation)
SECONDARYHLAGADAL
Environmental Monitoring & Cleanroom Testing (GMP)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPABAAAK
Compliance, Risk & EHS Management
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Specialty Cleaning, Polishing And Sanitation Preparations2842
Product category
Pharmaceutical Manufacturing Services
Cost components6 values
Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Azzur Group provides GMP-compliant cleanroom hosting, environmental monitoring, GMP cleaning and disinfection, and GMP warehouse/material storage services to pharmaceutical and biotechnology manufacturers through its Chrysalis platform. The company also offered consulting services (divested to ELIQUENT Life Sciences in 2025) and Azzur Labs / Cleanroom on Demand capabilities, helping biotech and pharma clients launch manufacturing operations in 4 to 6 weeks without long-term build-out commitments.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Azzur Group operated as a services company offering consulting services. The company underwent restructuring under Chapter 11 bankruptcy, during which it reached an agreement to sell its consulting business to ELIQUENT Life Sciences for $56 million through a court-supervised sale process supported by DIP financing. No other product offerings, platform architecture, or integrated product suite are described in the available source data.

Product and service1 record
1Cleanroom Hosting (Chrysalis)
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeOthersAnnounced on2025-03-02
Description

Azzur Group reached an agreement to sell its consulting business to ELIQUENT Life Sciences for $56 million. The transaction was part of Azzur's restructuring process under Chapter 11 bankruptcy and was facilitated through a court-supervised sale process with DIP financing support.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Thermo Fisher's Patheon CDMO business offers large-scale GMP manufacturing including viral vector and cell therapy services, competing with Azzur Labs for biotech manufacturing clients with deeper balance-sheet capacity.

TypeDirect peer
Description

Vibalogics is a specialized CDMO focused on viral vectors and gene therapy manufacturing with GMP cleanroom infrastructure, directly comparable to Chrysalis' gene therapy and viral vector manufacturing support.

TypeBroad incumbent
Description

Catalent is a large, diversified CDMO with extensive GMP manufacturing capacity including cell and gene therapy suites, serving as a broad incumbent competitor to Azzur Labs in the same customer base.

TypeDirect peer
Description

SK Pharmteco's Centre for Breakthrough Medicines unit provides cell and gene therapy manufacturing capacity with a flexible, multi-modality CDMO model that overlaps directly with Azzur Labs' ATMP-focused cleanroom offering.

TypeDirect peer
Description

Resilience operates a network of flexible biomanufacturing facilities offering GMP suites and services across modalities including cell and gene therapy, directly comparable to Chrysalis' multi-site cleanroom hosting model.

TypeBroad incumbent
Description

Lonza is the world's largest CDMO with substantial cell and gene therapy manufacturing capacity and global cleanroom infrastructure, representing a well-capitalized incumbent alternative to Azzur Labs' offering.

TypeBroad incumbent
Description

AGC Biologics is a global CDMO offering GMP manufacturing across biologics and advanced therapies; its flexible, multi-modality manufacturing approach overlaps with Azzur Labs' ATMP manufacturing support services.

8Lykan Bioscience
TypeDirect peer
Description

Lykan is a cell therapy-focused CDMO with dedicated GMP cleanroom capacity and process development services, competing for the same early-to-mid-phase clinical cell therapy manufacturers targeted by Chrysalis.

TypeEmerging player
Description

Akron Bio supplies raw materials and ancillary GMP manufacturing services to cell and gene therapy developers; it is a smaller, emerging player that addresses overlapping customer needs around advanced therapy manufacturing infrastructure.

TypeBroad incumbent
Description

Charles River provides a broad suite of biopharma services including manufacturing support, quality/compliance, and CDMO capabilities that overlap with both the historical Azzur consulting business and ongoing Azzur Labs GMP services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles16 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Azzur Group

Pharmaceutical Manufacturing Servicesazzur.com

Azzur Group firmographics

Firmographics
Name
Azzur Group
Website
https://azzur.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Azzur Group industry classification

Industry
Product category
Pharmaceutical Manufacturing Services
SIC
Services-Commercial Physical & Biological Research (8731), Specialty Cleaning, Polishing And Sanitation Preparations (2842)
akta.pro industry
PRIMARYHLAAAKAH
GMP Manufacturing Support Services (QA/QMS, validation, documentation)
SECONDARYHLAGADAL
Environmental Monitoring & Cleanroom Testing (GMP)
SECONDARYHLAGAKAJ
Manufacturing Quality Assurance & GMP Compliance (batch release, deviation/CAPA, tech transfer QA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPABAAAK
Compliance, Risk & EHS Management
SECONDARYHLAGAKAD
Quality Management Systems (QMS) & GxP Documentation
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • GMP cleanroom hosting
  • Pharmaceutical manufacturing services
  • Biotech facility services
  • Environmental monitoring services
  • GMP warehouse storage

Where Azzur Group is headquartered

Location

Headquarters

HQ city
Burlington
HQ country
United States
HQ region
North America

Markets served

Azzur Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Azzur Group product offering

Product offering

Core offering

Azzur Group provides GMP-compliant cleanroom hosting, environmental monitoring, GMP cleaning and disinfection, and GMP warehouse/material storage services to pharmaceutical and biotechnology manufacturers through its Chrysalis platform. The company also offered consulting services (divested to ELIQUENT Life Sciences in 2025) and Azzur Labs / Cleanroom on Demand capabilities, helping biotech and pharma clients launch manufacturing operations in 4 to 6 weeks without long-term build-out commitments.

Product overview

Azzur Group operated as a services company offering consulting services. The company underwent restructuring under Chapter 11 bankruptcy, during which it reached an agreement to sell its consulting business to ELIQUENT Life Sciences for $56 million through a court-supervised sale process supported by DIP financing. No other product offerings, platform architecture, or integrated product suite are described in the available source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cleanroom Hosting (Chrysalis)

Companies that use Azzur Group

Customer profile

Ideal customer profiles2 records

Azzur Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Azzur Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • ELIQUENT Life SciencesminorOthers · 2 March 2025Azzur Group reached an agreement to sell its consulting business to ELIQUENT Life Sciences for $56 million. The transaction was part of Azzur's restructuring process under Chapter 11 bankruptcy and was facilitated through a court-supervised sale process with DIP financing support.

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Azzur Group competitors and assessment

Company assessment

Broad incumbents

  • Thermo Fisher Scientific (Patheon CDMO): Thermo Fisher's Patheon CDMO business offers large-scale GMP manufacturing including viral vector and cell therapy services, competing with Azzur Labs for biotech manufacturing clients with deeper balance-sheet capacity.
  • Catalent: Catalent is a large, diversified CDMO with extensive GMP manufacturing capacity including cell and gene therapy suites, serving as a broad incumbent competitor to Azzur Labs in the same customer base.
  • Lonza: Lonza is the world's largest CDMO with substantial cell and gene therapy manufacturing capacity and global cleanroom infrastructure, representing a well-capitalized incumbent alternative to Azzur Labs' offering.
  • AGC Biologics: AGC Biologics is a global CDMO offering GMP manufacturing across biologics and advanced therapies; its flexible, multi-modality manufacturing approach overlaps with Azzur Labs' ATMP manufacturing support services.
  • Charles River Laboratories: Charles River provides a broad suite of biopharma services including manufacturing support, quality/compliance, and CDMO capabilities that overlap with both the historical Azzur consulting business and ongoing Azzur Labs GMP services.

Direct peers

  • Vibalogics: Vibalogics is a specialized CDMO focused on viral vectors and gene therapy manufacturing with GMP cleanroom infrastructure, directly comparable to Chrysalis' gene therapy and viral vector manufacturing support.
  • SK Pharmteco (Centre for Breakthrough Medicines): SK Pharmteco's Centre for Breakthrough Medicines unit provides cell and gene therapy manufacturing capacity with a flexible, multi-modality CDMO model that overlaps directly with Azzur Labs' ATMP-focused cleanroom offering.
  • National Resilience: Resilience operates a network of flexible biomanufacturing facilities offering GMP suites and services across modalities including cell and gene therapy, directly comparable to Chrysalis' multi-site cleanroom hosting model.
  • Lykan Bioscience: Lykan is a cell therapy-focused CDMO with dedicated GMP cleanroom capacity and process development services, competing for the same early-to-mid-phase clinical cell therapy manufacturers targeted by Chrysalis.

Emerging players

  • Akron Bio: Akron Bio supplies raw materials and ancillary GMP manufacturing services to cell and gene therapy developers; it is a smaller, emerging player that addresses overlapping customer needs around advanced therapy manufacturing infrastructure.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Azzur Group social profiles

Digital presence

Azzur Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Azzur Group leadership team

Management profile

Number of profiles

Profiles16 records

Azzur Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Azzur Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Azzur Group

What does Azzur Group do?

Azzur Group provides GMP-compliant cleanroom hosting, environmental monitoring, GMP cleaning and disinfection, and GMP warehouse/material storage services to pharmaceutical and biotechnology manufacturers through its Chrysalis platform. The company also offered consulting services (divested to ELIQUENT Life Sciences in 2025) and Azzur Labs / Cleanroom on Demand capabilities, helping biotech and pharma clients launch manufacturing operations in 4 to 6 weeks without long-term build-out commitments.

Is Azzur Group a public or private company?

Azzur Group is a private company. It is classified as venture growth investor backed and is currently operating.

When was Azzur Group founded?

Azzur Group was founded in 2010. It employs 101 to 250 people.

Where is Azzur Group based?

Azzur Group is headquartered in Burlington, United States, in the North America region.

Who are Azzur Group's main competitors?

Broad incumbents on record are Thermo Fisher Scientific (Patheon CDMO), Catalent, Lonza, AGC Biologics and Charles River Laboratories. Direct peers are Vibalogics, SK Pharmteco (Centre for Breakthrough Medicines), National Resilience and Lykan Bioscience. Akron Bio is listed as an emerging player.

Does Azzur Group have an API?

No public API is recorded for Azzur Group.

What industry is Azzur Group in?

Azzur Group's product category is Pharmaceutical Manufacturing Services. Its primary akta.pro industry code is HLAAAKAH, GMP Manufacturing Support Services (QA/QMS, validation, documentation), with a secondary code of HLAGADAL, Environmental Monitoring & Cleanroom Testing (GMP). Its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AETOSWireELIQUENT Life Sciences Announces Strategic Acquisition of Azzur Consulting – Strengthening Full-Service Quality & Compliance CapabilitiesELIQUENT Life Sciences acquired Azzur Consulting, a quality and validation engineering firm, to strengthen its full-service platform. The integration adds capabilities in commissioning, qualification, and validation, as well as IT system validation, across North America, Europe, Japan, and other markets.PR NewswireAzzur Group ("Azzur") Reaches Agreement to Sell Consulting Business for $56 Million to ELIQUENT Life SciencesAzzur Group agreed to sell its consulting business to ELIQUENT Life Sciences for $56 million, with ELIQUENT acting as stalking horse in a Chapter 11 sale process. The company secured $23.5 million in DIP financing from M&T Bank to support operations during the sale.Cleanroom TechnologyRentable cleanroom company Chrysalis launches following Azzur acquisitionChrysalis has launched as a rentable cleanroom provider by acquiring facility assets from the bankrupt Azzur Group. The new company will operate GMP-ready cleanroom facilities in Massachusetts and North Carolina to support life sciences and biopharma clients with flexible manufacturing capacity.PR NewswireAzzur Group Names Project Management Expert, Rob Chapman, Director of its Raleigh-Based Consulting OperationAzzur Group announced the appointment of Rob Chapman as Director of Azzur Raleigh, its GxP advisory and consulting operation serving the life science industry in the southeastern United States. Chapman brings over 30 years of engineering and project management experience in the regulated pharmaceutical sector, having previously served as Director of the Global Project Management Office at Fujifilm Diosynth Biotechnologies. The appointment is intended to enhance Azzur Raleigh's GMP service offerings and client satisfaction in the life science consulting space.YahooAzzur Group Names Project Management Expert, Rob Chapman, Director of its Raleigh-Based Consulting OperationAzzur Group appointed Rob Chapman as Director of its Raleigh-based consulting operation, Azzur Raleigh. Chapman brings over 30 years of engineering and project management experience in the regulated pharmaceutical and life science space. He will advance GMP service offerings for manufacturers in the Southeastern U.S.ContractpharmaAzzur Group Introduces Analytical Laboratory Testing ServicesAzzur Group introduced analytical laboratory testing services for advanced therapeutic medicinal products, including assay and protocol development, study design, and analytical testing. The company also offers Azzur Cleanrooms on Demand, combining manufacturing infrastructure with compliance expertise without facility ownership. The services aim to support cell and gene therapy development with GMP-compliant, phase-appropriate solutions.PR NewswireAzzur Group Expands Service Portfolio with Analytical Services for Advanced Therapeutics, enhancing the Azzur Discovery to Delivery PlatformAzzur Group announced the introduction of analytical laboratory testing services for advanced therapeutic medicinal products (ATMPs), expanding its Discovery to Delivery platform to address the growing cell and gene therapy pipeline. The new services include assay and protocol development, study design and execution, and analytical/bioanalytical testing, providing fit-for-purpose GMP solutions for the 3,000+ advanced therapies in development globally. The expansion positions Azzur Group to enable pharmaceutical and biotechnology companies in delivering novel cell and gene therapies while meeting stringent regulatory requirements.YahooAzzur Group Expands Service Portfolio with Analytical Services for Advanced Therapeutics, enhancing the Azzur Discovery to Delivery PlatformAzzur Group announced analytical laboratory testing services for advanced therapeutic medicinal products, including assay development and GMP testing. The company states there are over 3,000 advanced therapies in development and 124 approved. The services are part of its Azzur Discovery to Delivery platform.PR NewswireAzzur Group Appoints James Kalinovich as Chief Financial OfficerAzzur Group appointed James Kalinovich as Chief Financial Officer, succeeding Matt Weiss. Kalinovich brings over 20 years of finance experience, including roles at Wabtec, Avantor, and American Water. He will support growth of Azzur's professional services units.PR NewswireAzzur Group Appoints Senior Executive, Sarah Stevens, Ph.D., as President of Azzur Labs & Azzur Cleanrooms on Demand™Azzur Group announced the appointment of Sarah Stevens as President of Azzur Labs and Azzur Cleanrooms on Demand, effective immediately. Stevens brings 20 years of industry experience, having most recently served as Senior Vice President and Head of Early Development at Quotient Sciences. She will oversee operations and strategy across all Azzur Labs and Azzur COD locations spanning Massachusetts, North Carolina, Illinois, and California.